SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma.

Young, TL; Whisenhunt, KN; Jin, J; LaMartina, SM; Martin, SM; Souma, T; Limviphuvadh, V; Suri, F; Souzeau, E; Zhang, X; et al. Young, TL; Whisenhunt, KN; Jin, J; LaMartina, SM; Martin, SM; Souma, T; Limviphuvadh, V; Suri, F; Souzeau, E; Zhang, X; Dan, Y; Anagnos, E; Carmona, S; Jody, NM; Stangel, N; Higuchi, EC; Huang, SJ; Siggs, OM; Simões, MJ; Lawson, BM; Martin, JS; Elahi, E; Narooie-Nejad, M; Motlagh, BF; Quaggin, SE; Potter, HD; Silva, ED; Craig, JE; Egas, C; Maroofian, R; Maurer-Stroh, S; Bradfield, YS; Tompson, SW (2020) SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma. Invest Ophthalmol Vis Sci, 61 (12). p. 6. ISSN 1552-5783 https://doi.org/10.1167/iovs.61.12.6
SGUL Authors: Maroofian, Reza

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (7MB) | Preview

Abstract

Purpose: Affecting children by age 3, primary congenital glaucoma (PCG) can cause debilitating vision loss by the developmental impairment of aqueous drainage resulting in high intraocular pressure (IOP), globe enlargement, and optic neuropathy. TEK haploinsufficiency accounts for 5% of PCG in diverse populations, with low penetrance explained by variable dysgenesis of Schlemm's canal (SC) in mice. We report eight families with TEK-related PCG, and provide evidence for SVEP1 as a disease modifier in family 8 with a higher penetrance and severity. Methods: Exome sequencing identified coding/splice site variants with an allele frequency less than 0.0001 (gnomAD). TEK variant effects were assayed in construct-transfected HEK293 cells via detection of autophosphorylated (active) TEK protein. An enucleated eye from an affected member of family 8 was examined via histology. SVEP1 expression in developing outflow tissues was detected by immunofluorescent staining of 7-day mouse anterior segments. SVEP1 stimulation of TEK expression in human umbilical vascular endothelial cells (HUVECs) was measured by TaqMan quantitative PCR. Results: Heterozygous TEK loss-of-function alleles were identified in eight PCG families, with parent-child disease transmission observed in two pedigrees. Family 8 exhibited greater disease penetrance and severity, histology revealed absence of SC in one eye, and SVEP1:p.R997C was identified in four of the five affected individuals. During SC development, SVEP1 is secreted by surrounding tissues. SVEP1:p.R997C abrogates stimulation of TEK expression by HUVECs. Conclusions: We provide further evidence for PCG caused by TEK haploinsufficiency, affirm autosomal dominant inheritance in two pedigrees, and propose SVEP1 as a modifier of TEK expression during SC development, affecting disease penetrance and severity.

Item Type: Article
Additional Information: Copyright 2020 The Authors This work is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0).
Keywords: Ophthalmology & Optometry, 11 Medical and Health Sciences, 06 Biological Sciences
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Invest Ophthalmol Vis Sci
ISSN: 1552-5783
Language: eng
Dates:
DateEvent
7 October 2020Published
8 September 2020Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
R01 EY025799NEI NIH HHSUNSPECIFIED
P30 EY016665NEI NIH HHSUNSPECIFIED
R01 HL124120NHLBI NIH HHSUNSPECIFIED
U01 HG007674NHGRI NIH HHSUNSPECIFIED
T32 DK108738NIDDK NIH HHSUNSPECIFIED
R01 EY014685NEI NIH HHSUNSPECIFIED
P30 DK114857NIDDK NIH HHSUNSPECIFIED
APP1116360National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
APP1107098National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
APP1154824National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
SFRH/BD/90445/2012Foundation for Science and TechnologyUNSPECIFIED
H18/01/a0/b14Agency for Science Technology and ResearchUNSPECIFIED
940012Iran National Science Foundationhttp://dx.doi.org/10.13039/501100003968
P30EY016665National Eye Institutehttp://dx.doi.org/10.13039/100000053
UO1HG007674National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
PubMed ID: 33027505
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112614
Publisher's version: https://doi.org/10.1167/iovs.61.12.6

Actions (login required)

Edit Item Edit Item